Ambulatory Blood Pressure Monitoring (ABPM): Bringing Precision to Hypertension Management

Ambulatory Blood Pressure Monitoring (ABPM): Bringing Precision to Hypertension Management

Hypertension continues to be one of the leading modifiable risk factors for cardiovascular disease, stroke, chronic kidney disease, and premature mortality in India. Despite advances in treatment, many patients remain either undiagnosed or inadequately controlled. One of the major reasons is the reliance on isolated clinic blood pressure measurements, which may not accurately reflect the patient’s true blood pressure profile. Ambulatory Blood Pressure Monitoring (ABPM) has therefore emerged as an invaluable tool in modern hypertension practice.

ABPM refers to the automated recording of blood pressure over a 24‑hour period while the patient continues normal daily activities and sleep. Measurements are usually taken every 15–30 minutes during daytime and every 30–60 minutes during night-time. Unlike office blood pressure recordings, ABPM provides a dynamic assessment of blood pressure behaviour across the entire circadian cycle. It helps clinicians identify white-coat hypertension, masked hypertension, nocturnal hypertension, dipping patterns, morning surges, and resistant hypertension.

Current international hypertension guidelines strongly support the use of ABPM in clinical practice. The 2023 European Society of Hypertension (ESH) Guidelines and the 2024 European Society of Cardiology (ESC) Guidelines both emphasise out‑of‑office blood pressure measurement as an essential component of diagnosis and management of hypertension.

Why is ABPM Needed?

Traditional office blood pressure measurement has several limitations. Blood pressure is inherently variable and can fluctuate due to stress, anxiety, physical activity, sleep, medications, pain, or even the presence of medical personnel. Many patients exhibit elevated blood pressure in clinics but have normal readings at home — the so‑called “white-coat hypertension.” Conversely, some individuals demonstrate normal office readings but elevated ambulatory pressures, termed “masked hypertension.” Both situations may lead to inappropriate treatment decisions if ABPM is not utilised.

ABPM provides several advantages:

• Better correlation with cardiovascular outcomes compared to office BP.
• Detection of nocturnal hypertension.
• Assessment of blood pressure variability.
• Identification of dipping and non‑dipping patterns.
• Confirmation of resistant hypertension.
• Evaluation of antihypertensive drug efficacy over 24 hours.
• Improved risk stratification.

Several landmark studies have demonstrated the prognostic superiority of ABPM over clinic BP measurements. The Dublin Outcome Study showed that ambulatory blood pressure was a stronger predictor of cardiovascular mortality than clinic blood pressure. Similarly, the Ohasama Study from Japan demonstrated the importance of nocturnal hypertension and non‑dipping status in predicting stroke and cardiovascular risk.

How is ABPM Performed?

ABPM is relatively simple to perform but requires proper patient education for optimal results.

A portable blood pressure monitor is attached to the patient’s waist or shoulder with an inflatable cuff placed on the non‑dominant arm. The device is programmed to record BP at predetermined intervals over 24 hours.

Patients are instructed to:

• Continue normal daily activities.
• Avoid vigorous exercise during monitoring.
• Keep the arm still during cuff inflation.
• Maintain a diary of symptoms, activities, sleep times, medications, and stressful events.
• Avoid tampering with the machine.

At the end of the recording period, data are downloaded and analysed using specialised software.

A valid ABPM recording usually requires:

• At least 70% successful readings.
• Minimum 20 daytime readings.
• Minimum 7 night-time readings.

Definitions of Hypertension in ABPM

According to current ESH and ESC recommendations:

• 24‑hour average BP: ≥130/80 mmHg
• Daytime (awake) BP: ≥135/85 mmHg
• Night-time (asleep) BP: ≥120/70 mmHg

Categories of Hypertension Detected by ABPM

1. Sustained Hypertension
   Both office and ambulatory BP are elevated.
2. White-Coat Hypertension
   Office BP is elevated but ambulatory BP is normal.
3. Masked Hypertension
   Office BP appears normal but ambulatory BP is elevated.
4. Nocturnal Hypertension
   Night-time BP remains elevated despite acceptable daytime readings.
5. Resistant Hypertension
   Blood pressure remains uncontrolled despite three antihypertensive drugs including a diuretic.

Dippers and Non‑Dippers

Normally, blood pressure falls during sleep due to reduced sympathetic activity. This physiological fall is called “dipping.”

• Normal dipper: 10–20% fall
• Non‑dipper: <10% fall
• Extreme dipper: >20% fall
• Reverse dipper: BP rises at night

Non‑dipping and reverse dipping patterns are associated with significantly higher cardiovascular and renal risk. These patterns are commonly seen in chronic kidney disease, diabetes mellitus, elderly patients, obstructive sleep apnoea, autonomic dysfunction, and heart failure.

Morning Blood Pressure Surge

ABPM also helps identify exaggerated morning blood pressure surge, which is associated with increased risk of stroke, myocardial infarction, and sudden cardiac death.

Clinical Indications for ABPM

• Suspected white-coat hypertension
• Suspected masked hypertension
• Resistant hypertension
• Episodic hypertension
• Evaluation of hypotensive symptoms
• Autonomic dysfunction
• Assessment of nocturnal hypertension
• Hypertension in pregnancy
• Elderly patients with variable BP
• Hypertension in CKD and diabetes
• Syncope evaluation
• Monitoring treatment efficacy

Indications for Treatment Based on ABPM

Treatment is generally indicated when:

• 24‑hour BP ≥130/80 mmHg
• Daytime BP ≥135/85 mmHg
• Night-time BP ≥120/70 mmHg

Patients with masked hypertension particularly benefit from treatment because their cardiovascular risk approximates that of sustained hypertension.

ABPM in Chronic Kidney Disease

ABPM has special relevance in nephrology. Hypertension in CKD is frequently characterised by nocturnal hypertension, non‑dipping status, increased BP variability, and masked uncontrolled hypertension.

Studies have shown that ambulatory BP correlates better with renal outcomes and left ventricular hypertrophy than office BP in CKD patients.

Limitations of ABPM

Despite its advantages, ABPM has some limitations:

• Cost and limited availability.
• Patient discomfort during sleep.
• Motion artefacts causing erroneous readings.
• Limited reproducibility in some patients.

Conclusion

Ambulatory Blood Pressure Monitoring has revolutionised the diagnosis and management of hypertension. It provides a comprehensive picture of blood pressure behaviour beyond the clinic environment and identifies clinically significant patterns that would otherwise remain undetected.

Routine incorporation of ABPM into clinical practice — particularly in patients with resistant hypertension, CKD, diabetes, and suspected masked or white‑coat hypertension — can substantially improve hypertension management and cardiovascular risk reduction.

References

1. 2023 European Society of Hypertension Guidelines for the Management of Arterial Hypertension.
2. 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension.
3. Parati G et al. European Society of Hypertension Practice Guidelines for Ambulatory Blood Pressure Monitoring.
4. Lee EM et al. When and how to use ambulatory blood pressure monitoring in clinical practice.
5. Ohasama Study — Prognostic significance of ambulatory blood pressure monitoring in cardiovascular risk prediction.

Dr. R. Balasubramaniyam
Chief Nephrologist,
Kauvery Hospital, Chennai.

Dr. Balaji Kirushnan
Senior Consultantn Nephrologist,
Kauvery Hospital, Chennai.

Dr Rashmi Shivram
Associate Consultant Nephrologist,
Kauvery Hospital, Chennai.